Histamine 2 receptor: Emerging target for the treatment of attention-deficit/hyperactivity disorder
A study by An et al. sheds a novel light on the potential role of histamine 2 receptor (H<sub>2</sub>R) deficiency in attention-deficit/hyperactivity disorder (ADHD), which could be a future therapeutic target of ADHD. This spotlight provides an overview of the current knowledge of the histaminergic system and proposes future directions.
Authors
- Dick F. Swaab (ORCID: https://orcid.org/0000-0002-9665-7845)
- Ling Shan (ORCID: https://orcid.org/0000-0002-4765-2474)
Institutions
- Netherlands Institute for Neuroscience (NL)
- Royal Netherlands Academy of Arts and Sciences (NL)
Publication Details
- Journal
- Cell Reports Medicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.xcrm.2025.102023
- Primary Topic
- Neurotransmitter Receptor Influence on Behavior
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Zhejiang University
- Stichting ALS Nederland